(Q55059985)

16 June 2018

title

Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. (English)

1 reference

16 June 2018

1 reference

4

1 reference

16 June 2018

author name string

J M Barnes

1

1 reference

16 June 2018

N M Barnes

2

1 reference

16 June 2018

B Costall

3

1 reference

16 June 2018

R J Naylor

5

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 December 1989

1 reference

16 June 2018

Journal of Neurochemistry

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 June 2018

volume

53

1 reference

16 June 2018

page(s)

1787-1793

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

[3H]zacopride: ligand for the identification of 5-HT3 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Identification of 5-HT3 recognition sites in the ferret area postrema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Zacopride: anxiolytic profile in rodent and primate models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Zacopride, a potent 5-HT3 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09244.X

10.1111/J.1471-4159.1989.TB09244.X

21 January 2018

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

2809591

1 reference

16 June 2018